Navigation Links
Key Signaling Switch Identified in Allergic Disease

A research team has identified a key enzyme responsible for triggering a chain of events that results in allergic reaction, according to new study findings published online// this week in Nature Immunology.

The work by researchers from Virginia Commonwealth University, the Hospital for Special Surgery and Weill Cornell Medical College in New York sets the stage for development of new strategies and target therapies that control allergic disease – the sixth leading cause of chronic disease in the United States.

Allergic diseases such as asthma and hay fever are problematic for about 30 percent of the population in the developed world. Researchers have developed various treatments to control allergy, but no cure has been found.

The team has demonstrated, for the first time, the role of a proteolytic enzyme called ADAM10 that releases a major allergy regulatory protein from the surface of cells and thereby promotes a stronger allergic response. The identification of drugs that inhibit ADAM10’s ability to release this molecule could revolutionize treatment of asthma and allergic disease.

“Our research, for the first time, may represent a treatment strategy to prevent, rather than simply control IgE-mediated allergy,” said Daniel Conrad, Ph.D., a professor in VCU’s Department of Microbiology and Immunology. Conrad directed the research conducted at VCU. IgE is an antibody known to trigger Type I allergic disease.

“Understanding ADAM10’s role in allergic disease makes it a potential target for the design of drugs to treat asthma and allergic disease,” he said.

According to Conrad, the outcome of allergic disease can be modulated by high levels of the regulatory protein, known as CD23, which ultimately results in a decreased production of IgE. He said that when the regulatory protein is released from the cell surface by ADAM10 there is an increase in the production of IgE and therefore, increased al lergy.

“These exciting results extend the known functions of ADAMs in development and disease. We hope our results will stimulate new research into how to block or activate the function of ADAMs involved in human disease, including allergic response, cancer and rheumatoid arthritis,” said Carl P. Blobel, M.D., Ph.D, chair of the Arthritis and Tissue Degeneration Program at the Hospital for Special Surgery, and professor of Medicine and of Physiology and Biophysics at Weill Cornell Medical College. Blobel directed the research conducted at Weill Cornell.

According to Blobel, in addition to the critical role of ADAM10 in allergic disease through processing of CD23, ADAMs are also key molecules in cancer and rheumatoid arthritis. For example, he said, ADAMs are essential for activating the epidermal growth factor receptor, an established target for the treatment of cancers, such as colon cancer. Moreover, ADAMs release tumor necrosis factor alpha, currently the major target for treatment of rheumatoid arthritis.

Since the 1970s Conrad has been investigating the basic mechanism involved in allergic disease. Blobel has been investigating ADAM proteases since their discovery in the early 1990s.

Source-Newswie
SRM
'"/>




Related medicine news :

1. Chemical Signaling Helps Regulate Sensory Map Formation In The Brain
2. Hh Signaling May Play Role In Fat Formation
3. Birth Defects Caused By Deficiencies In Cell Signaling Pathway
4. Lake Superior in US Losing Ice Cover Fast, Signaling Global Warming
5. Switching drugs regularly improves HIV treatment
6. Protein acts as "Master Switch" that cuts off cells Cancer-Growth machinery
7. In The Habit Of Taking Painkillers For Your Chronic Headache? Time To Switch Over
8. Unusual Tumor-Suppressor Gene Switches Off in Lung Cancer
9. Switching Off Protein Could Play Key Role In Success Of Radiation Therapy For Cancer
10. Reduced Weight Gain Is Seen In People Who Switch To A Vegetarian Diet
11. Breast Cancer Treatment Switches to more Modern Therapy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... March 29, 2017 , ... Altima Technologies, Inc., the maker ... data center assets and audio-video devices has recently updated its Visio Stencils library ... free and download shapes and stencils from http://www.VisioStencils.com. , New devices ...
(Date:3/29/2017)... , ... March 29, 2017 , ... Immunotherapy has emerged ... number of cancers and is touted to be the next revolution in our fight ... has been in the form of immune checkpoint inhibitors such as PD-1 and PD-L1 ...
(Date:3/29/2017)... ... ... AvePoint , the Microsoft Cloud expert, is pleased to announce the ... the Riverfront Plaza, 901 East Byrd Street. AvePoint is celebrating with a ribbon-cutting ceremony ... Mayor of Richmond Levar M. Stoney. , Founded in 2001, AvePoint employs more than ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s Chigurupati Technologies ... directly address the resolution to globally reduce the harmful use of alcohol set ... FDA and TTB approved ingredients that when infused into alcohol, renders the alcohol ...
(Date:3/28/2017)... ... March 29, 2017 , ... Dr. Isabella Wentz, PharmD, FASCP, one ... video series titled The Thyroid Secret. Dr. Wentz talked about journey and research recently ... fact that medication IS NOT the only solution to deal with thyroid disease. ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... HOUSTON , March 29, 2017  The leader ... announced that Drs. Sam Daher , Manal ... and David Couchat will be the featured microlecture ... the upcoming American Association of Orthodontists (AAO) Annual Session, ... to attend the microlectures beginning daily at 11:20 a.m. ...
(Date:3/29/2017)... , March 29, 2017  Maxor National Pharmacy ... announced that it has named Leah Bailey ... all divisions of the company. With more ... the previous 8 years focused on health care, Bailey ... her tenure at Prime, Bailey advised the PBM, Specialty, ...
(Date:3/29/2017)... SAN JOSE, Calif. , March 29, 2017 /PRNewswire/ ... can now significantly reduce solution size by 50% and ... (I Q ) power management integrated circuit (PMIC) from ... The wearable PMIC supports a low input voltage of ... as Zinc Air and Silver Oxide, as well as ...
Breaking Medicine Technology: